NDC 31722-506 – LAMIVUDINE and ZIDOVUDINE

Lamivudine 150 mg/1; Zidovudine 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC31722-506

Product details

Brand name
LAMIVUDINE and ZIDOVUDINE
Generic name
LAMIVUDINE and ZIDOVUDINE
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA079124
Marketed since
September 18, 2015
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for LAMIVUDINE and ZIDOVUDINE →

Package NDC codes (2)

Package NDCDescriptionSince
31722-506-05500 TABLET, FILM COATED in 1 BOTTLE (31722-506-05)Sep 18, 2015
31722-506-6060 TABLET, FILM COATED in 1 BOTTLE (31722-506-60)Sep 18, 2015

Other LAMIVUDINE and ZIDOVUDINE products